169 related articles for article (PubMed ID: 36183499)
1. The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle.
Mizuma K; Takashima A; Cubitt B; de la Torre JC; Iwasaki M
Virology; 2022 Nov; 576():83-95. PubMed ID: 36183499
[TBL] [Abstract][Full Text] [Related]
2. A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
Cubitt B; Ortiz-Riano E; Cheng BY; Kim YJ; Yeh CD; Chen CZ; Southall NOE; Zheng W; Martinez-Sobrido L; de la Torre JC
Antiviral Res; 2020 Jan; 173():104667. PubMed ID: 31786250
[TBL] [Abstract][Full Text] [Related]
3. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
[TBL] [Abstract][Full Text] [Related]
4. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
Hashizume M; Takashima A; Iwasaki M
J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
[TBL] [Abstract][Full Text] [Related]
5. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
[TBL] [Abstract][Full Text] [Related]
6. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098811
[TBL] [Abstract][Full Text] [Related]
7. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library.
Lan X; Zhang Y; Jia X; Dong S; Liu Y; Zhang M; Guo J; Cao J; Guo Y; Xiao G; Wang W
Antiviral Res; 2022 Jan; 197():105230. PubMed ID: 34965446
[TBL] [Abstract][Full Text] [Related]
8. A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein.
Iwasaki M; de la Torre JC
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593035
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.
Caì Y; Iwasaki M; Beitzel BF; Yú S; Postnikova EN; Cubitt B; DeWald LE; Radoshitzky SR; Bollinger L; Jahrling PB; Palacios GF; de la Torre JC; Kuhn JH
Viruses; 2018 Nov; 10(11):. PubMed ID: 30463334
[TBL] [Abstract][Full Text] [Related]
10. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
11. Chaperonin TRiC/CCT Participates in Mammarenavirus Multiplication in Human Cells via Interaction with the Viral Nucleoprotein.
Sakabe S; Witwit H; Khafaji R; Cubitt B; de la Torre JC
J Virol; 2023 Feb; 97(2):e0168822. PubMed ID: 36656012
[TBL] [Abstract][Full Text] [Related]
12. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.
Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC
mBio; 2020 Mar; 11(2):. PubMed ID: 32209677
[TBL] [Abstract][Full Text] [Related]
13. Plasmid-Based Lassa Virus Reverse Genetics.
Martínez-Sobrido L; Ye C; de la Torre JC
Methods Mol Biol; 2024; 2733():115-131. PubMed ID: 38064030
[TBL] [Abstract][Full Text] [Related]
14. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
[TBL] [Abstract][Full Text] [Related]
15. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
Iwasaki M; Minder P; Caì Y; Kuhn JH; Yates JR; Torbett BE; de la Torre JC
PLoS Pathog; 2018 Feb; 14(2):e1006892. PubMed ID: 29462184
[TBL] [Abstract][Full Text] [Related]
16. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
17. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y
Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674
[TBL] [Abstract][Full Text] [Related]
18. E3 Ligase ITCH Interacts with the Z Matrix Protein of Lassa and Mopeia Viruses and Is Required for the Release of Infectious Particles.
Baillet N; Krieger S; Carnec X; Mateo M; Journeaux A; Merabet O; Caro V; Tangy F; Vidalain PO; Baize S
Viruses; 2019 Dec; 12(1):. PubMed ID: 31906112
[TBL] [Abstract][Full Text] [Related]
19. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
Oppliger J; Torriani G; Herrador A; Kunz S
J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735
[TBL] [Abstract][Full Text] [Related]
20. Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.
Kim YJ; Cubitt B; Cai Y; Kuhn JH; Vitt D; Kohlhof H; de la Torre JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
